0,894  0,002  Dopamine D1 antagonist
0,869  0,002  Dopamine D2 agonist
0,839  0,003  Dopamine agonist
0,837  0,003  5 Hydroxytryptamine release stimulant
0,790  0,002  Tyrosine 3 hydroxylase inhibitor
0,763  0,002  Dopamine D5 antagonist
0,765  0,004  UGT1A9 substrate
0,748  0,003  5 Hydroxytryptamine 7 antagonist
0,720  0,004  Dopamine antagonist
0,720  0,007  Antiparkinsonian
0,699  0,002  Pneumotoxic
0,683  0,004  Dopamine D2 antagonist
0,669  0,003  Alpha 2a adrenoreceptor antagonist
0,657  0,004  Muscle relaxant
0,640  0,010  Spasmolytic
0,624  0,004  Skeletal muscle relaxant
0,632  0,015  Respiratory analeptic
0,623  0,006  Hypoxia-inducible factor 1 alpha inhibitor
0,631  0,015  Aldehyde oxidase inhibitor
0,595  0,003  Alpha 2b adrenoreceptor antagonist
0,604  0,014  CYP2C19 substrate
0,593  0,008  Cardiodepressant
0,584  0,004  Alpha 2 adrenoreceptor antagonist
0,612  0,034  Caspase 9 stimulant
0,582  0,005  Sigma receptor agonist
0,580  0,004  Cyclic AMP phosphodiesterase inhibitor
0,577  0,018  Vasodilator, peripheral
0,562  0,016  CYP2D6 substrate
0,552  0,007  Sedative
0,579  0,034  Transcription factor NF kappa B inhibitor
0,544  0,005  Alpha adrenoreceptor antagonist
0,543  0,005  UGT1A3 substrate
0,565  0,032  CYP3A4 substrate
0,519  0,004  Alpha 2c adrenoreceptor antagonist
0,536  0,030  CYP2C9 substrate
0,505  0,005  Calcium channel activator
0,518  0,025  Antidepressant
0,483  0,004  Antitussive
0,501  0,022  Analeptic
0,486  0,012  Antineoplastic enhancer
0,471  0,005  5 Hydroxytryptamine 2B antagonist
0,464  0,005  Antialcoholic
0,459  0,005  Toxic, respiratory center
0,520  0,068  Apoptosis agonist
0,483  0,033  Mood disorders treatment
0,479  0,030  CYP2C19 inhibitor
0,470  0,026  Cardioprotectant
0,478  0,036  Prostate cancer treatment
0,468  0,030  Antipsychotic
0,458  0,022  CYP2D6 inhibitor
0,436  0,005  5 Hydroxytryptamine 1A antagonist
0,444  0,017  Vasodilator
0,435  0,008  5 Hydroxytryptamine 2 antagonist
0,427  0,002  Prolactin inhibitor
0,433  0,010  Antiparkinsonian, rigidity relieving
0,431  0,009  Male reproductive disfunction treatment
0,426  0,005  5 Hydroxytryptamine 1 antagonist
0,464  0,047  Antileukemic
0,420  0,010  5 Hydroxytryptamine antagonist
0,411  0,006  Alpha 1 adrenoreceptor antagonist
0,457  0,053  Antineoplastic (lung cancer)
0,408  0,004  Dopamine D3 antagonist
0,463  0,063  Antineoplastic (breast cancer)
0,451  0,054  15-Lipoxygenase inhibitor
0,416  0,020  Dependence treatment
0,410  0,016  FMO3 substrate
0,415  0,025  Antipyretic
0,406  0,021  Psychostimulant
0,418  0,036  CYP1A2 substrate
0,437  0,056  Histamine release inhibitor
0,385  0,005  5 Hydroxytryptamine 1F antagonist
0,385  0,005  Dopamine D4 antagonist
0,378  0,004  Opioid kappa receptor antagonist
0,405  0,037  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,374  0,007  Acetylcholine M1 receptor antagonist
0,379  0,014  UGT2B7 substrate
0,372  0,009  Erectile dysfunction treatment
0,369  0,007  5 Hydroxytryptamine 1E antagonist
0,367  0,008  5 Hydroxytryptamine 2A antagonist
0,376  0,020  Anesthetic general
0,355  0,004  5 Hydroxytryptamine 5A antagonist
0,370  0,020  UGT1A1 substrate
0,400  0,053  Antineoplastic (colorectal cancer)
0,370  0,024  UDP-glucuronosyltransferase substrate
0,390  0,052  Antineoplastic (colon cancer)
0,374  0,037  UGT2B4 substrate
0,369  0,033  Antihypoxic
0,348  0,013  Genotoxic
0,335  0,004  5 Hydroxytryptamine 5 antagonist
0,355  0,024  5 Hydroxytryptamine uptake stimulant
0,341  0,011  Antiadrenergic
0,328  0,002  Dopamine D1 agonist
0,389  0,064  Ulceration
0,405  0,082  Analgesic
0,329  0,007  Expectorant
0,345  0,023  UGT1A4 substrate
0,329  0,013  Antiparkinsonian, tremor relieving
0,324  0,008  Alpha 1a adrenoreceptor antagonist
0,324  0,008  UGT2B9 substrate
0,352  0,038  Free radical scavenger
0,376  0,066  Stroke treatment
0,323  0,012  Adrenaline antagonist
0,343  0,034  Flavin-containing monooxygenase substrate
0,389  0,082  TNF expression inhibitor
0,312  0,013  Cholinergic antagonist
0,334  0,036  Antimitotic
0,304  0,007  LDLR expression enhancer
0,314  0,018  Tubulin antagonist
0,307  0,013  Acetylcholine antagonist
0,318  0,026  P-glycoprotein inhibitor
0,328  0,040  Pyruvate kinase inhibitor
0,331  0,043  Tumour necrosis factor alpha release inhibitor
0,300  0,013  Antidiarrheal
0,306  0,021  Antineoplastic (squamous cell carcinoma)
0,328  0,044  Antiamyloidogenic
0,302  0,018  Cholinergic
0,290  0,007  Acetylcholine nicotinic antagonist
0,296  0,016  Antidote
0,289  0,014  M18 aspartyl aminopeptidase inhibitor
0,323  0,054  Antioxidant
0,278  0,010  5 Hydroxytryptamine 2C antagonist
0,270  0,006  Opioid antagonist
0,270  0,007  Constipation treatment
0,276  0,014  Cocaine dependence treatment
0,289  0,030  Antimigraine
0,262  0,007  Sigma receptor antagonist
0,318  0,063  Sodium/bile acid cotransporter inhibitor
0,256  0,004  Restless leg syndrome treatment
0,268  0,016  Anesthetic local
0,261  0,010  VEGF expression inhibitor
0,294  0,046  UGT1A6 substrate
0,257  0,011  UGT2B10 substrate
0,280  0,034  DNA methylase inhibitor
0,320  0,076  Antithrombotic
0,303  0,060  Antihypercholesterolemic
0,244  0,005  Antineoplastic alkaloid
0,243  0,005  Opioid mu receptor antagonist
0,308  0,075  12-Lipoxygenase inhibitor
0,242  0,011  Alpha 1b adrenoreceptor antagonist
0,251  0,020  Acetylcholinesterase inhibitor
0,234  0,006  Alpha adrenoreceptor agonist
0,282  0,057  Superoxide dismutase inhibitor
0,318  0,094  Cognition disorders treatment
0,231  0,007  Neuronal nicotinic receptor antagonist
0,248  0,028  UGT2B15 substrate
0,283  0,064  DNA damaging
0,289  0,072  Radioprotector
0,236  0,020  Uterine stimulant
0,245  0,030  Anesthetic
0,263  0,049  Antiarrhythmic
0,218  0,005  Alpha 1 adrenoreceptor agonist
0,220  0,009  Opioid delta receptor antagonist
0,293  0,082  Caspase 3 stimulant
0,294  0,086  AR expression inhibitor
0,239  0,031  Antiseptic
0,233  0,026  Aldehyde oxidase substrate
0,214  0,009  Analgesic, opioid
0,214  0,009  Alpha 1d adrenoreceptor antagonist
0,228  0,025  Neuropathy treatment
0,287  0,087  CYP3A4 inhibitor
0,221  0,021  Alkylator
0,203  0,005  Opioid mu receptor agonist
0,218  0,021  Cystathionine beta-synthase inhibitor
0,216  0,021  Acetylcholine muscarinic antagonist
0,240  0,045  Neurotrophic factor enhancer
0,238  0,047  Hepatoprotectant
0,199  0,008  Myasthenia Gravis treatment
0,247  0,057  Antihypotensive
0,256  0,070  Cardiovascular analeptic
0,188  0,004  Narcotic antagonist
0,187  0,004  5 Hydroxytryptamine 7 agonist
0,184  0,005  Alpha 2 adrenoreceptor agonist
0,255  0,075  Teratogen
0,214  0,036  Lipid peroxidase inhibitor
0,195  0,017  UGT2B1 substrate
0,183  0,005  Opioid kappa receptor agonist
0,232  0,058  Mutagenic
0,203  0,029  Toll-Like receptor antagonist
0,181  0,010  5 Hydroxytryptamine 1B antagonist
0,246  0,074  Antineoplastic (liver cancer)
0,320  0,149  Alzheimer's disease treatment
0,176  0,006  Opioid agonist
0,179  0,013  Antiviral (Papilloma)
0,211  0,045  Antineoplastic (gastric cancer)
0,172  0,009  5 Hydroxytryptamine 1D antagonist
0,240  0,077  NOS2 expression inhibitor
0,269  0,115  Vasodilator, coronary
0,255  0,101  Anxiolytic
0,234  0,081  Acute neurologic disorders treatment
0,169  0,018  AMP-activated protein kinase stimulant
0,179  0,028  Antiprotozoal (Amoeba)
0,243  0,092  Radiosensitizer
0,234  0,086  Antineoplastic (non-small cell lung cancer)
0,200  0,054  Antimutagenic
0,175  0,029  Antismoking
0,192  0,046  Antiischemic, cerebral
0,210  0,065  Abortion inducer
0,241  0,097  Antineoplastic (ovarian cancer)
0,252  0,108  CTGF expression inhibitor
0,208  0,065  DNA methyltransferase I inhibitor
0,144  0,002  Prolactin release inhibitor
0,272  0,133  Immunosuppressant
0,187  0,049  Antineoplastic (carcinoma)
0,276  0,139  Antipruritic, allergic
0,246  0,112  Hepatic disorders treatment
0,210  0,076  Sensitization
0,145  0,014  Tocolytic
0,216  0,085  Embryotoxic
0,253  0,124  FMO1 substrate
0,178  0,051  NOS3 expression enhancer
0,157  0,030  Nav1.1 sodium channel blocker
0,138  0,014  Beta tubulin antagonist
0,216  0,091  Antineoplastic (cervical cancer)
0,212  0,089  Cytostatic
0,154  0,031  Choleretic
0,129  0,008  5 Hydroxytryptamine 2A agonist
0,189  0,072  Nitric oxide antagonist
0,148  0,032  Bronchodilator
0,141  0,026  Toll-Like receptor 4 antagonist
0,155  0,043  Antihelmintic (Trematoda)
0,120  0,009  Nicotinic receptor alpha7 subunit antagonist
0,192  0,081  Cytotoxic
0,124  0,016  Nicotinic alpha4beta2 receptor antagonist
0,218  0,112  Antineoplastic (melanoma)
0,131  0,026  UGT2B11 substrate
0,111  0,008  5 Hydroxytryptamine 2 agonist
0,163  0,060  Protein kinase stimulant
0,127  0,024  Phosphodiesterase I inhibitor
0,154  0,052  NADPH oxidase inhibitor
0,129  0,030  Calcium antagonist
0,109  0,011  Uterine relaxant
0,292  0,195  Antineoplastic (solid tumors)
0,130  0,035  Electron transport complex I inhibitor
0,161  0,067  Carcinogenic, group 1
0,213  0,118  Antineoplastic (pancreatic cancer)
0,230  0,138  Prostaglandin dehydrogenase inhibitor
0,220  0,128  NOS3 expression inhibitor
0,217  0,127  Antiischemic
0,093  0,005  Dopamine D5 agonist
0,107  0,019  Female sexual dysfunction treatment
0,105  0,017  Dopamine uptake inhibitor
0,195  0,107  RNA-directed DNA polymerase inhibitor
0,176  0,090  CYP2B6 inhibitor
0,123  0,037  HIV-1 integrase (Overall Integration) inhibitor
0,094  0,008  5 Hydroxytryptamine 4 antagonist
0,207  0,122  Amyotrophic lateral sclerosis treatment
0,099  0,015  5 Hydroxytryptamine 6 antagonist
0,204  0,120  Proliferative diseases treatment
0,143  0,061  Ca2+-transporting ATPase inhibitor
0,104  0,023  HIV-1 integrase inhibitor
0,202  0,122  Antineoplastic (sarcoma)
0,169  0,089  Sleep disorders treatment
0,088  0,009  5 Hydroxytryptamine 1B agonist
0,205  0,126  Antineoplastic (bladder cancer)
0,186  0,108  Antineoplastic (glioma)
0,107  0,031  5 Hydroxytryptamine agonist
0,105  0,030  Antiprotozoal activity enhancer
0,124  0,049  Protein kinase C gamma inhibitor
0,140  0,067  Antifungal enhancer
0,174  0,101  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,132  0,059  Topoisomerase II inhibitor
0,123  0,050  Estrogen antagonist
0,077  0,005  Sigma 2 receptor antagonist
0,084  0,012  Nicotinic receptor alpha4 subunit antagonist
0,124  0,052  SULT1A1 substrate
0,089  0,017  Alpha tubulin antagonist
0,111  0,039  Protein kinase C zeta inhibitor
0,113  0,042  Estrogen receptor beta antagonist
0,159  0,089  Tumour necrosis factor antagonist
0,158  0,088  ATPase inhibitor
0,270  0,201  5 Hydroxytryptamine release inhibitor
0,108  0,039  Histamine N-methyltransferase inhibitor
0,078  0,009  Dopamine D3 agonist
0,130  0,062  Antineoplastic (uterine cancer)
0,085  0,018  Dopamine D4 agonist
0,165  0,098  Amyloid beta aggregation inhibitor
0,160  0,094  Phobic disorders treatment
0,137  0,072  Toll-Like receptor 9 antagonist
0,219  0,155  Antineoplastic (osteosarcoma)
0,110  0,047  Breast cancer-resistant protein inhibitor
0,077  0,014  Nicotinic alpha3beta2 receptor antagonist
0,198  0,137  Chemoprotective
0,133  0,073  Amylase inhibitor
0,109  0,050  Creatine kinase inhibitor
0,095  0,037  Phosphodiesterase XI inhibitor
0,095  0,037  Phosphodiesterase 11A inhibitor
0,091  0,034  Estrogen receptor alpha antagonist
0,285  0,229  Antiinflammatory
0,076  0,021  5 Hydroxytryptamine 1A agonist
0,092  0,037  Estrogen-related receptor beta agonist
0,119  0,067  Antifungal (Pneumocystis)
0,131  0,080  Neurotrophic factor
0,059  0,010  Opioid delta receptor agonist
0,220  0,171  Antiprotozoal (Plasmodium)
0,075  0,027  Acetylcholine M5 receptor antagonist
0,063  0,015  Factor III inhibitor
0,183  0,136  Cardiotonic
0,178  0,132  Vascular (periferal) disease treatment
0,138  0,091  GABA C receptor rho-2 antagonist
0,056  0,009  Sigma 1 receptor antagonist
0,074  0,028  Beta 3 adrenoreceptor antagonist
0,058  0,012  5 Hydroxytryptamine 3B antagonist
0,067  0,022  Ryanodine receptor antagonist
0,102  0,056  Tourette's syndrome treatment
0,097  0,052  SULT1E1 substrate
0,102  0,057  Obsessive-compulsive disorder treatment
0,110  0,066  Endometrios treatment
0,066  0,022  Dopamine transporter inhibitor
0,108  0,065  Multidrug resistance-associated protein 1 inhibitor
0,103  0,060  Sulfotransferase substrate
0,084  0,042  Acetylcholine M4 receptor antagonist
0,046  0,003  NMDA receptor phencyclidine site antagonist
0,059  0,017  NMDA receptor subunit 3A antagonist
0,112  0,071  Microtubule formation inhibitor
0,072  0,031  NMDA 2C receptor antagonist
0,083  0,043  Antidote, organophosphates
0,105  0,066  Topoisomerase I inhibitor
0,133  0,093  Heat shock protein 90 antagonist
0,059  0,020  Nicotinic receptor alpha3 subunit antagonist
0,092  0,052  NMDA receptor antagonist
0,060  0,021  5 Hydroxytryptamine 2C agonist
0,105  0,066  DOPA decarboxylase inhibitor
0,130  0,091  SULT1A3 substrate
0,151  0,113  Non-steroidal antiinflammatory agent
0,067  0,029  5 Hydroxytryptamine 1 agonist
0,045  0,007  Nicotinic alpha3beta4 receptor agonist
0,079  0,043  Histidine decarboxylase inhibitor
0,176  0,140  Hypoglycemic
0,072  0,036  Beta adrenoreceptor antagonist
0,149  0,114  Succinate dehydrogenase inhibitor
0,107  0,072  Acetylcholine release stimulant
0,105  0,070  5 Hydroxytryptamine 3A agonist
0,072  0,038  HIV-1 integrase (3'-Processing) inhibitor
0,098  0,063  Butyrylcholinesterase inhibitor
0,209  0,175  GST M1-1 substrate
0,072  0,039  Glutamate (mGluR7) antagonist
0,058  0,026  Glucose-6-phosphate translocase inhibitor
0,115  0,083  Toll-Like receptor 2 antagonist
0,047  0,015  Vesicle monoamine transporter inhibitor
0,041  0,009  Dopamine autoreceptor agonist
0,064  0,032  Beta 1 adrenoreceptor antagonist
0,144  0,113  Platelet adhesion inhibitor
0,066  0,036  Calcium channel P-type blocker
0,096  0,066  Antiemetic
0,083  0,054  CC chemokine 5 receptor agonist
0,045  0,017  5 Hydroxytryptamine 2B agonist
0,149  0,121  Antineoplastic (glioblastoma multiforme)
0,121  0,094  Psychosexual dysfunction treatment
0,065  0,039  HIV-1 integrase (Strand Transfer) inhibitor
0,166  0,140  VCAM1 expression inhibitor
0,081  0,056  Acetylcholine nicotinic agonist
0,111  0,087  Antiviral (Influenza B)
0,116  0,092  Antihemorrhagic
0,179  0,155  DNA synthesis inhibitor
0,120  0,096  Nav1.6 sodium channel blocker
0,165  0,142  ErbB-1 antagonist
0,051  0,031  Topoisomerase II beta inhibitor
0,061  0,040  Phosphodiesterase 1B inhibitor
0,060  0,041  Phosphodiesterase 1A inhibitor
0,132  0,114  Antipruritic, non-allergic
0,047  0,029  Potassium channel small-conductance Ca-activated blocker
0,068  0,050  SULT2A1 substrate
0,032  0,015  5 Hydroxytryptamine 6 agonist
0,032  0,015  Nicotinic alpha4beta2 receptor agonist
0,091  0,075  Chronic obstructive bronchitis treatment
0,121  0,104  Chemopreventive
0,065  0,049  Acetylcholine M5 receptor agonist
0,060  0,045  Acetylcholine M2 receptor antagonist
0,217  0,203  Antineoplastic (small cell lung cancer)
0,058  0,044  Heat shock protein 90 beta antagonist
0,038  0,025  Nicotinic receptor beta4 subunit antagonist
0,050  0,037  Beta 2 adrenoreceptor antagonist
0,088  0,075  Sphingomyelinase inhibitor
0,082  0,069  Granulocyte macrophage colony stimulating factor agonist
0,042  0,030  Guanylate cyclase inhibitor
0,075  0,064  Adrenaline agonist
0,219  0,208  Antibacterial
0,124  0,115  Adenylate cyclase stimulant
0,140  0,131  Catenin beta inhibitor
0,068  0,060  CDC25A inhibitor
0,068  0,060  Glycine receptor agonist
0,079  0,071  mTOR complex 2 inhibitor
0,144  0,136  Antihypertriglyceridemic
0,069  0,062  NAD(P)H dehydrogenase (quinone) inhibitor
0,044  0,037  Antibiotic Glycopeptide-like
0,019  0,014  Vesicular acetylcholine transporter inhibitor
0,054  0,049  Acetylcholine M3 receptor antagonist
0,049  0,045  Alpha 1L adrenoreceptor antagonist
0,082  0,078  MAO A inhibitor
0,129  0,125  Heat shock protein 70 antagonist
0,076  0,073  Antiviral (Trachoma)
0,015  0,013  Nicotinic alpha4 receptor agonist
0,129  0,128  Movement disorders treatment

